Started his career at Mérieux Développement in 2016. Prior to his current assignment, Dan spent five years at L.E.K. Consulting in Boston, specializing in the life sciences practice. In that role, he served as a strategic advisor to a broad range of corporate clients and life science investors developing deep expertise in corporate strategy and transaction support.
Dan was awarded a Ph.D. in Biomedical Sciences from the University of California, San Diego where he studied the cell signaling basis and engineering applications of Eph receptor signaling. He also holds a Bachelor of Arts degree in Biology from Rhode Island College.
He is Board Observer of Xeris Pharmaceuticals.